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The human respiratory syncytial virus (HRSV) is 
considered the major cause of lower respiratory tract in-
fections in children (Gardner et al. 1967, Kesson 2007) 
and an important agent of acute respiratory infection in 
the elderly and immunocompromised patients accounting 
for more than 50% of the mortality rate in human stem 
cell transplant patients (HSCT) (Ebbert & Limper 2005).
Several laboratory techniques have been used in the 
diagnosis of HRSV, differing in sensitivity, cost and time 
to obtain results (Landry & Ferguson 2000). The aim of 
this study was to evaluate the better diagnostic flow for 
HRSV detection among patients in the HSCT using the 
following techniques: direct immunofluorescence assay 
(DFA), immunochromatographic point-of-care RSV Bio 
Easy® (PC) assay and polymerase chain reaction (PCR). 
For evaluation of the possible relation between RSV 
circulation in community and HSCT patients infec-
tion these techniques were applied in conjunction with 
a community survey among children presenting acute 
respiratory symptoms suspected of viral infection. 
A total of 230 samples were collected from two pa-
tient groups presenting with the symptoms of acute re-
spiratory infection from March-December 2008. 
In the first group, 102 nasal wash samples were col-
lected from 67 haematological unit patients at the São 
Paulo Hospital: 36 were stem cell transplant patients, 30 
were non-transplant patients and one did not have the 
record number on this questionnaire, so we could not 
retrieve information about transplant data. Twenty-two 
patients had more than one sample collected. 
The second group included 128 nasopharyngeal aspi-
rates from 119 children from the primary care centre. A 
questionnaire with epidemiological and clinical aspects 
for the study was applied. This study was approved by 
the Ethical Committee of São Paulo Federal University 
(CEP 0257/2007). Written consent was obtained from all 
patients or their parents or guardians.
The samples were processed using previously pub-
lished procedures (Bellei et al. 2007). 
The DFA was performed using the Simulfluor Respi-
ratory Screen and Panel kit (Chemicon Int, EUA). A pool 
of monoclonal antibodies to detect seven respiratory vi-
ruses: influenza A (flu), flu B, parainfluenza (PIV) 1, 2 
and 3, adenovirus (Adv) and HRSV.
Nucleic acids were extracted from 200 µL aliquots 
that had been stored at -80ºC using the QIAmp DNA 
Blood kit (Qiagen, Germany), according to the manufac-
turer’s recommendations.
The primers and methodology used for the detection 
of HRSV on the extracted material have been previous-
ly described (Erdman et al. 2003). These primers target 
the conserved region of the F gene, which encodes the 
viral fusion protein and generates a fragment of 380 
nucleotide base pairs.
Electrophoresis in a 1.5% agarose gel (Invitrogen, 
USA) was performed on each of the amplified products. 
Viral isolation was performed using Hep-2 cells cul-
tured using minimum essential medium with 10% foetal 
bovine serum and incubated in a CO2 incubator at 37ºC. 
A tissue culture infectious dose 50 (TCID50) titration of a 
sample previously isolated in cell culture was performed 
using the method of Reed and Muench (1938).
The 1:10 dilution made for the TCID50 was used for 
the reverse transcriptase (RT)-PCR sensitivity test. A 
viral titre of 1.2 x 106 TCID50/mL was found in the con-
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trol sample, and the threshold of detection using RT-PCR 
was determined to be 0.12 TCID50/mL.
We used the commercial RSV Test Bioeasy kit 
(Bioeasy, Brazil), a qualitative immunochromatograph-
ic assay that detects antigens of HRSV. A hundred tests 
were provided by the company and they were used to test 
the samples from the stem cell transplantation program 
group of patients.
Statistical analyses were performed using a two-by-
two table in Microsoft Office Excel version 2007, fixing 
the diagnostic RT-PCR as the gold standard. A Fisher 
exact test was conducted to assess the associations be-
tween the categorical variables, with a two-tailed signif-
icance level of p < 0.05. The Kappa test was performed 
using the R program version 2.11.1, 
Overall, 16.1% (37/230) of the samples were positive 
for HRSV. The positivity in the children’s group was 
14.1% (18/128), while in the HSCT patient group it was 
18.6% (19/102). 
In the paediatric population, 128 samples were col-
lected from 119 children. Additional samples were only 
collected from the same child if it occurred 15 days after 
the end of a previous infection episode, which character-
ized a new episode. The mean age was 3.2 years (range: 
1 month to 11 years). The time from the onset of symp-
toms until the sample collection date had a mean and 
median of three days (range: 1 to 12 days).
In the same period, 102 samples from 67 patients 
with different types of haematologic malignancies were 
collected (Table I). Among them, 44.8% (30/66) were 
non-transplant and 53.7% (36/66) were transplant pa-
tients. The patient who had no available information 
about transplant was excluded from this analysis. Of the 
remaining 36 transplant patients, 70.6% (24/34) had allo-
geneic transplantation and 29.4% (10/34) had autologous 
transplantation. One of the 67 patients had two distinct 
episodes of RSV in 2008.
HRSV occurrence was observed between the months 
of March and September, with a clear peak among children 
observed in the viral distribution in April. In the HSCT 
patient group, the distribution was homogeneous between 
the months of March and June. The frequency of cases in 
the two groups was similar in the first month of the study.
The percentage of patients positive for HRSV ac-
cording to each test for the two patients groups are 
shown in Table II. 
In the pediatric group, 11 samples were positive us-
ing DFA and RT-PCR, showing a concordance of 94.5% 
between these techniques. Three samples were positive 
via RT-PCR exclusively.
The Fig. 1 shows the distribution of the positive sam-
ples among the paediatric and the HSCT patient group 
according to assay. When the 91 samples were evaluated 
in parallel, an overall concordance of 84.6% was ob-
served. When the PC data were excluded and the result-
ing 102 samples were analyzed with RT-PCR and DFA, 
seven samples were positive, 83 were negative and 12 
were discordant, showing a concordance of 88.4%.
When the RT-PCR assay was used as the gold stan-
dard for the paediatric group, the sensitivity, specific-
ity, predictive positive value (PPV), negative predictive 
value (NPV) and kappa coefficient for DFA were 83.3%, 
100%, 100%, 97.3% and 0.89%, respectively. For the 
HSCT group, the sensitivity, specificity, PPV, NPV and 
kappa coefficient were 50%, 94.3%, 58.3%, 92.2% and 
0.48% for DFA, respectively, and 33.3%, 100%, 100%, 
90.8% and 0.46% for PC, respectively.
The positive cases from the samples of the paediatric 
group collected more than five days following symptom 
TABLE I
Number of patients, total number of samples and  
human respiratory syncytial virus positive samples  
per haematologic malignancy diagnosis
Underling 
disease
Patients 
n (%)
Samples 
n (%)
Positive 
samples 
n (%)
Leukemia 19 (28.8) 27 (26.7) 4 (22.2)
Lymphoma 22 (33.3) 37 (36.6) 7 (38.9)
Other 25 (37.9) 37 (36.6) 7 (38.9)
Total 66 (100) 101 (100) 18 (100)
the median age of these patients was 48 years (range: 5-78 
years). The time delay between symptom onset and collection 
date had a median of three days (range: 1-27 days).
TABLE II
Percentage of human respiratory syncytial virus positive patients according to each test for the two groups
PC DFA RT-PCR
Tested
samples
Positive
n (%)
Tested
samples
Positive
n (%)
Tested 
samples
Positive 
n (%)
Children - - 128 15 (11.7) 128 18 (14)
HSCT 91 4 (4.4) 102 12 (11.8) 102 14 (13.7)
DFA: direct immunofluorescence assay; HSCT: human stem cell transplant patients; PC: immunochromatographic point-of-care 
RSV Bio Easy®; RT-PCR: reverse transcriptase-polymerase chain reaction.
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onset were detected exclusively with RT-PCR. For the 
HSCT group, both techniques detected positive cases 
five days after the onset of symptoms; however, the RT-
PCR had a higher sensitivity (Fig. 2).
The HRSV occurrence for the transplant patients was 
15.5% (9/58) and was 20.9% (9/43) for the non-transplant 
patients (no statistical difference) (Table III).
The 19 HRSV-positive samples from the HSCT 
group were obtained from 15 patients; seven of these 
patients died (46.7%). Five (33.3%) of these deaths were 
temporally related to the RSV infection. Three (60%) of 
the five deaths related to RSV infection occurred among 
transplant patients.
The monthly occurrence of HRSV was different for 
the two study groups. Among the children within the 
community, a viral detection rate of 14.1% was distrib-
uted during the autumn and winter months with a notice-
able peak in April, which is consistent with the previous-
ly reported data on seasonality of the virus in Southeast 
Brazil (Pecchini et al. 2008). In the HSCT group, a viral 
detection rate of 18.6% was distributed from March-
June with an absence of notable peaks which may be due 
to an outbreak that occurred in this period within the 
hospital ward and a result of the frequent re-evaluation 
of these patients to verify viral persistence. Importantly, 
the frequency of HRSV infections in both groups was 
the same in the first month of the study, which shows a 
possible link between the infection of HSCT patients and 
an increased circulation of the virus in the children of 
the community. Previous studies that analyzed the viral 
circulation and the rate of HRSV infection in immuno-
suppressed patients also demonstrated this relationship 
(Whimbey et al. 1996, 1997).
The detection of HRSV with RT-PCR was superior 
to all the other methods utilized, particularly in the sam-
ples of patients who had symptoms for longer than five 
days. The RT-PCR assay was able to detect three addi-
tional samples in the paediatric group and two additional 
samples in the HSCT group in comparison with the DFA, 
which was the test with the second highest positive rate 
for HRSV. These results were expected, particularly in 
TABLE III
Human respiratory syncytial virus occurrence  
in transplant and non-transplant patients
Population
Positive
n (%)
Negative
n (%)
Total
n (%)
Transplant 9 (15.5) 49 (84.5) 58 (100)
Non-transplant 9 (20.9) 34 (79.1) 43 (100)
Total 18a (17.8) 83 (82.2) 101 (100)
p 0.66
a: for one patient, the information regarding transplant status 
was not available.
Fig. 1: comparison of human respiratory syncytial virus (HRSV) de-
tection using three different techniques: direct immunofluorescence 
assay (DFA), immunochromatographic point-of-care RSV Bio Easy® 
assay (PC) and reverse transcriptase-polymerase chain reaction (RT-
PCR) in paediatric and human stem cell transplant patients (HSCT) 
patients. NA: not available; +: positive; -: negative; /: results were not 
found in the other possible combinations. 
Fig. 2: distribution of the respiratory syncytial virus detection for the 
paediatric group and the human stem cell transplant patients (HSCT) 
group by assay according to the time of symptom onset until sample 
collection. DFA: direct immunofluorescence assay; PC: immuno-
chromatographic point-of-care RSV Bio Easy® assay; RT-PCR: re-
verse transcriptase-polymerase chain reaction. 
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cases of decreased viral shedding (Kuypers et al. 2009). 
It is also important to consider that viral shedding in im-
munosuppressed patients can be longer, and thus, viral 
detection can occur over prolonged periods.
Despite the convenience and speed of the results pro-
vided by the PC test, the low sensitivity of HRSV detec-
tion in the samples of the immunosuppressed patients 
does not justify its use in routine diagnosis. Further-
more, due to the commercial variabilities found between 
brands, it is important to compare different test brands 
and types (Kuroiwa et al. 2004, Deiman et al. 2007). 
As shown by the high mortality rate temporally related 
to HRSV infections in the HSCT patients (33.3%), HRSV 
represents a great risk for immunosuppressed patients; 
however, other respiratory viruses, such as flu, Adv and 
PIV, also have the potential to affect these patients (Rabel-
la et al. 1999, Hassan et al. 2003). Thus, diagnosis by DFA 
is useful in these patients because it enables the detection 
of respiratory viruses other than HRSV. However, based 
on our concordance tests results, an association between 
the tests, such as DFA followed by RT-PCR for HRSV on 
negative samples, is the best way to diagnose high-risk 
patients. In conclusion, we suggest a continuous surveil-
lance of respiratory viruses in high-risk patients using 
DFA as a routine method, but during high-risk seasons, a 
combination of molecular methods should be used to in-
crease the efficiency of the diagnosis. 
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